Abstract
Background
Silicone lymphadenopathy after implantation of silicone breast implants is a foreign body reaction due to the release or migration of silicone into the tissues surrounding the breast implant.
Methods
For the study, 14 cases of silicone lymphadenopathy were identified from the authors’ files. Four patients had been implanted before 2000 and had various types of implants. The remaining 10 patients all were implanted between 2006 and 2009, and all had Poly Implant Prothèse (PIP) implants. In addition to an analysis of the authors’ own cases, a thorough bibliographic search was initiated to identify all reports of lymphadenopathy related to silicone breast implants.
Results
The implant age of the four patients implanted before 2000 was 12–34 years (mean, 17.25 years). The implant age of the 10 patients implanted after 2000 was 2–6 years (mean 3.45 years). The literature search identified 29 papers with case reports of silicone lymphadenopathy published between 1978 and 2012, with a total of 175 cases. Usable data were extracted from 164 of the 175 cases. Of these patients, 159 were implanted before (and including) the year 2000 and had a mean age of 11 years at presentation or explantation, and 5 of these patients were implanted after the year 2000 and had a mean age of 4.6 years at presentation or explantation . After inclusion of the authors’ own cases, the mean age of the implants at presentation or explantation was 10.56 years in a total of 178 cases. Of these patients, 163 were implanted before (and including) the year 2000 and had a mean age of 11.16 years at presentation or explantation, and 15 of these patients were implanted after the year 2000 and had a mean age of 4.06 years at presentation or explantation.
Conclusions
Current breast implant technology has minimized the release of silicone gel due to rupture or bleeding of silicone and its migration into the surrounding tissues, thus reducing the rate of silicone lymphadenopathy in the last 10 years. The PIP implant scandal highlights the fact that disregard for the implant manufacturing technologies and standards in favor of higher profits increased rupture rates and gel diffusion, leading to increased local complication rates. Silicone lymphadenopathy is a foreign body reaction that does not warrant treatment unless it is symptomatic or interferes with breast cancer detection.
Level of Evidence III
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Similar content being viewed by others
References
Breast Implant (2011) Wikipedia, vol. 2011, Retrieved 1 Mar 2012 at http://en.wikipedia.org/wiki/Breast_implant
Maxwell GP, Gabriel A (2009) The evolution of breast implants. Clin Plast Surg 36:1–13
Bondurant S, Ernster V, Herdman R (2005) Safety of silicone breast implants. National Academies, Washington, pp 1–559
Brody GS (1997) On the safety of breast implants. Plast Reconstr Surg 100:1314–1321
Yu LT, Latorre G, Marotta J et al (1996) In vitro measurement of silicone bleed from breast implants. Plast Reconstr Surg 97:756–764
SCENIHR (2012) The Safety of PIP Silicone Breast Implants. European Commission. Retrieved 1 Mar 2012 at http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_034.pdf
Barr S, Bayat A (2011) Breast implant surface development: perspectives on development and manufacture. Aesthet Surg J 31:56–67
Rohrich RJ, Adams WP, Beran SJ et al (1998) An analysis of silicone gel-filled breast implants: diagnosis and failure rates. Plast Reconstr Surg 102:2304–2308 discussion 2309
Spear SL, Murphy DK, Slicton A et al (2007) Inamed silicone breast implant core study results at 6 years. Plast Reconstr Surg 120:8S–16S discussion 17S–18S
Cunningham B (2007) The mentor core study on silicone memory gel breast implants. Plast Reconstr Surg 120:19S–29S discussion 30S–32S
Hausner RJ, Schoen FJ, Pierson KK (1978) Foreign-body reaction to silicone gel in axillary lymph nodes after an augmentation mammaplasty. Plast Reconstr Surg 62:381–384
Rohrich RJ (2002) Breast implant-related silicone granulomas: the literature and the litigation by Eric David Austad, MD. Plast Reconstr Surg 109:1731
van Diest PJ, Beekman WH, Hage JJ (1998) Pathology of silicone leakage from breast implants. J Clin Pathol 51:493–497
Barnard JJ, Todd EL, Wilson WG et al (1997) Distribution of organ silicon polymers in augmentation mammaplasties at autopsy. Plast Reconstr Surg 100:197–203 discussion 204–195
Austad ED (2002) Breast implant-related silicone granulomas: the literature and the litigation. Plast Reconstr Surg 109:1724–1730 discussion 1731–1722
Katzin WE, Centeno JA, Feng L-J et al (2005) Pathology of lymph nodes from patients with breast implants: a histologic and spectroscopic evaluation. Am J Surg Pathol 29:506–511
ASPS (2011) American Society of Plastic Surgeons Report of the 2010 Plastic Surgery Statistics. ASPS. pp. 1–25. Retrieved 1 Mar 2012 at http://www.plasticsurgery.org/Documents/news-resources/statistics/2010-statisticss/Top-Level/2010-US-cosmetic-reconstructive-plastic-surgery-minimally-invasive-statistics2.pdf
Wintsch W, Smahel J, Clodius L (1978) Local and regional lymph node response to ruptured gel-filled mammary prostheses. Br J Plast Surg 31:349–352
Hausner RJ, Schoen FJ, Mendez-Fernandez MA et al (1981) Migration of silicone gel to axillary lymph nodes after prosthetic mammoplasty. Arch Pathol Lab Med 105:371–372
Truong LD, Cartwright J, Goodman MD et al (1988) Silicone lymphadenopathy associated with augmentation mammaplasty: morphologic features of nine cases. Am J Surg Pathol 12:484–491
Tabatowski K, Elson CE, Johnston WW (1990) Silicone lymphadenopathy in a patient with a mammary prosthesis: fine needle aspiration cytology, histology, and analytical electron microscopy. Acta Cytol 34:10–14
Lin RP, DiLeonardo M, Jacoby RA (1993) Silicone lymphadenopathy: a case report and review of the literature. Am J Dermatopathol 15:82–84
Ahn CY, Shaw WW (1994) Regional silicone-gel migration in patients with ruptured implants. Ann Plast Surg 33:201–208
Rivero MA, Schwartz DS, Mies C (1994) Silicone lymphadenopathy involving intramammary lymph nodes: a new complication of silicone mammaplasty. AJR Am J Roentgenol 162:1089–1090
Kulber DA, Mackenzie D, Steiner JH et al (1995) Monitoring the axilla in patients with silicone gel implants. Ann Plast Surg 35:580–584
Vaamonde R, Cabrera JM, Vaamonde-Martin RJ et al (1997) Silicone granulomatous lymphadenopathy and siliconomas of the breast. Histol Histopathol 12:1003–1011
Kao CC, Rand RP, Holt CA et al (1997) Internal mammary silicone lymphadenopathy mimicking recurrent breast cancer. Plast Reconstr Surg 99:225–229
Santos-Briz A Jr, Lopez-Rios F, Santos-Briz A et al (1999) Granulomatous reaction to silicone in axillary lymph nodes: a case report with cytologic findings. Acta Cytol 43:1163–1165
Shaaban H, Jmor S, Alvi R (2003) Leakage and silicone lymphadenopathy with cohesive breast implant. Br J Plast Surg 56:518–519
Lahiri A, Waters R (2006) Locoregional silicone spread after high cohesive gel silicone implant rupture. Br J Plast Surg 59:885–886
Shipchandler TZ, Lorenz RR, McMahon J et al (2007) Supraclavicular lymphadenopathy due to silicone breast implants. Arch Otolaryngol Head Neck Surg 133:830–832
Khan UD (2008) Left unilateral breast autoinflation and intraprosthetic collection of sterile pus: an unusual operative finding of silicone gel bleed with silicone lymphadenitis. Aesthetic Plast Surg 32:684–687
Ganau S, Tortajada L, Rodríguez X et al (2008) Silicone lymphadenopathy: an unusual cause of internal mammary lymph node enlargement. Breast J 14:502–503
Accurso A, Rocco N, Feleppa C et al (2008) Spread of silicone to axillary lymph nodes after high cohesive gel silicone implant rupture. Plast Reconstr Surg 122:221e–222e
Tehrani H (2008) Lamberty BGH: axillary lymphadenopathy secondary to tattoo pigment and silicone migration. JPRAS J Plast Reconstr Aesthetic Surg 61:1381
Kaufman GJ, Sakr RA, Inguenault C et al (2009) Silicone migration to the contralateral axillary lymph nodes and breast after highly cohesive silicone gel implant failure: a case report. Cases J 2:6420
Gil T, Mettanes I, Aman B et al (2009) Contralateral internal mammary silicone lymphadenopathy imitates breast cancer metastasis. Ann Plast Surg 63:39–41
Dragu A, Theegarten D, Bach AD et al (2009) Intrapulmonary and cutaneous siliconomas after silent silicone breast implant failure. Breast J 15:496–499
Adams ST, Cox J, Rao GS (2009) Axillary silicone lymphadenopathy presenting with a lump and altered sensation in the breast: a case report. J Med Case Rep 3:6442
Takenaka M, Tanaka M, Isobe M et al (2009) Angiosarcoma of the breast with silicone granuloma: a case report. Kurume Med J 56:33–37
Dragoumis DM, Assimaki AS, Vrizas TI et al (2010) Axillary silicone lymphadenopathy secondary to augmentation mammaplasty. Indian J Plast Surg 43:206–209
Bauer PR, Krajicek BJ, Daniels CE et al (2011) Silicone breast implant-induced lymphadenopathy: 18 cases. Respir Med CME 4:126–130
Grubstein A, Cohen M, Steinmetz A et al (2011) Siliconomas mimicking cancer. Clin Imaging 35:228–231
Ksander GA, Vistnes LM (1985) The incidence of experimental contracture varies with the source of the prosthesis. Plast Reconstr Surg 75:668–676
Danino AM, Basmacioglu P, Saito S et al (2001) Comparison of the capsular response to the Biocell RTV and Mentor 1600 Siltex breast implant surface texturing: a scanning electron microscopic study. Plast Reconstr Surg 108:2047–2052
Adams WP Jr (2009) Capsular contracture: What is it? What causes it? How can it be prevented and managed? Clin Plast Surg 36:119–126 vii
Bergman RB, van der Ende AE (1979) Exudation of silicone through the envelope of gel-filled breast prostheses: an in vitro study. Br J Plast Surg 32:31–34
ISAPS (2012) The PIP problem. ISAPS News 6:3–5
Spear S (2006) The breast implant story. Ann Plast Surg 56:573–583
Stevens WG, Pacella SJ, Gear AJ et al (2008) Clinical experience with a fourth-generation textured silicone gel breast implant: a review of 1012 Mentor MemoryGel breast implants. Aesthet Surg J 28:642–647
FDA (2012) Regulatory history of breast implants in the U.S. Retrieved 1 May 2012 at http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm064461.htm
FDA (2011) Update on the safety of silicone gel-filled breast implants. Retrieved 14 May 2012 at www.fda.gov/breastimplants
MHRA (2011) Information for women considering breast implants. Retrieved 14 May 2012 at http://www.mhra.gov.uk/home/groups/dts-bi/documents/websiteresources/con2022634.pdf
FDA (2012) Breast implants: local complications and adverse outcomes. Retrieved 14 May 2012 at http://www.fda.gov/downloads/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/UCM259894.pdf
Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13
Acknowledgments
The authors acknowledge the help offered by Dr. Adrian Dragu and Mr. Hassan Shaaban with the information provided regarding their cases.
Conflict of interest
The authors declare that they have no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zambacos, G.J., Molnar, C. & Mandrekas, A.D. Silicone Lymphadenopathy After Breast Augmentation: Case Reports, Review of the Literature, and Current Thoughts. Aesth Plast Surg 37, 278–289 (2013). https://doi.org/10.1007/s00266-012-0025-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-012-0025-9